Introduction to Meniscus Tears
Meniscus tears involve damage to the cartilage structure within the knee joint that plays a critical role in shock absorption and joint stability. These injuries may occur due to sports activity, sudden twisting movements, or gradual wear over time, often influencing knee mobility and functional comfort. In regenerative medicine, umbilical cord–derived mesenchymal stem cells (MSCs) are increasingly explored as a supportive therapy aimed at assisting cartilage-environment balance, regulating inflammatory signaling, and encouraging natural tissue-support pathways under medical supervision.
In Turkey, stem cell therapy for meniscus conditions is performed using GMP-certified laboratory-processed biologic materials combined with individualized treatment planning. Because regenerative therapy focuses on biological support rather than structural surgical reconstruction, many individuals research this option as a complementary or non-surgical supportive approach following medical evaluation.
Meniscus Anatomy
The meniscus is a crescent-shaped cartilage structure located between the thigh bone and shin bone within the knee joint. Its primary function is to distribute weight evenly, absorb impact, and stabilize joint movement. When the meniscus is strained or torn, joint mechanics may be affected, leading individuals to seek supportive treatment strategies to maintain mobility and comfort.
MSC Role in Cartilage Support
Mesenchymal stem cells are studied for their paracrine signaling properties, meaning they release bioactive molecules that influence the surrounding tissue environment rather than directly replacing cartilage. These signaling pathways are explored for their potential role in inflammation modulation and cellular communication within the knee joint. For this reason, MSC therapy is described as regenerative biological support rather than structural cartilage reconstruction.
PRP Combination
In selected cases, physicians may recommend combining MSC therapy with Platelet-Rich Plasma (PRP) to enhance biological signaling pathways. PRP is derived from the patient’s own blood and contains growth factors associated with soft-tissue and collagen-support mechanisms. Combination protocols are determined through physician assessment and individualized treatment planning.
Treatment Steps
A typical regenerative meniscus-support pathway may include:
1
2
3
4
5
6
Treatment frequency and protocol design vary depending on clinical findings and functional goals.
Safety & Eligibility
Eligibility for regenerative therapy depends on physician evaluation, imaging reports, and individual medical history. Treatments are performed under sterile clinical standards using laboratory-tested biologic materials and professional medical supervision. Transparent communication, realistic expectations, and structured screening remain essential components of patient safety in cartilage-support planning.